Elnaiem Ahmed D, Hiramoto Brent, Flanagan Ryan, Muftah Mayssan, Shah Eric D, Chan Walter W
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
Harvard Medical School, Boston, MA, USA.
Dig Dis Sci. 2025 Mar;70(3):1142-1149. doi: 10.1007/s10620-024-08829-4. Epub 2025 Jan 18.
Chronic constipation, diarrhea, and fecal incontinence (FI) are prevalent with significant impact on quality of life and healthcare utilization. Thyroid dysfunction was recognized as a potential contributor to bowel disturbances in selected populations, but the strength/consistency of this association remain unclear.
To investigate the relationship between thyroid function and bowel health measures (constipation, diarrhea, and FI) in a nationally representative sample of the U.S.
We conducted a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) in 2005-2008. Adults aged ≥ 20 with TSH, free T4 (fT4), and bowel health data were included. Multivariable logistic regression models were constructed to examine associations between thyroid function and bowel health measures, adjusting for potential confounders.
Among 6,552 participants, 93.6%, 4.3%, 1.7%, and 0.4% had TSH levels of 0.24-5.4, 5.4-10, < 0.24, and ≥ 10 mIU/L, respectively. There were no significant differences in prevalence of thyroid dysfunction between individuals with constipation or diarrhea and those without. In fully adjusted models, TSH was not a significant predictor of constipation, diarrhea, or FI, but higher fT4 was protective against constipation as a continuous variable (OR 0.47, CI: 0.26-0.85, p = 0.014)). Neither hypothyroid nor hyperthyroid status significantly correlated with constipation or diarrhea, although hyperthyroidism was associated with FI (OR 3.58, CI:1.51-8.49, p = 0.005).
While bowel disturbances were common in this nationally representative sample, the yield of thyroid function testing was low. Overt hypo- and hyperthyroidism were not significantly associated with constipation or diarrhea. Clinical utility of routine thyroid testing for bowel symptoms may be low in patients without systemic manifestations of severe thyroid disease.
慢性便秘、腹泻和大便失禁(FI)很常见,对生活质量和医疗保健利用有重大影响。甲状腺功能障碍被认为是特定人群肠道紊乱的一个潜在因素,但这种关联的强度/一致性仍不清楚。
在美国具有全国代表性的样本中研究甲状腺功能与肠道健康指标(便秘、腹泻和FI)之间的关系。
我们对2005 - 2008年的美国国家健康与营养检查调查(NHANES)进行了横断面分析。纳入了年龄≥20岁且有促甲状腺激素(TSH)、游离甲状腺素(fT4)和肠道健康数据的成年人。构建多变量逻辑回归模型以检查甲状腺功能与肠道健康指标之间的关联,并对潜在混杂因素进行调整。
在6552名参与者中,TSH水平分别为0.24 - 5.4、5.4 - 10、<0.24和≥10 mIU/L的参与者比例分别为93.6%、4.3%、1.7%和0.4%。便秘或腹泻患者与无便秘或腹泻患者之间甲状腺功能障碍的患病率无显著差异。在完全调整的模型中,TSH不是便秘、腹泻或FI的显著预测因素,但较高的fT4作为连续变量对便秘有保护作用(比值比[OR]0.47,置信区间[CI]:0.26 - 0.85,p = 0.014)。甲状腺功能减退和甲状腺功能亢进状态与便秘或腹泻均无显著相关性,尽管甲状腺功能亢进与FI相关(OR 3.58,CI:1.51 - 8.49,p = 0.005)。
虽然在这个具有全国代表性的样本中肠道紊乱很常见,但甲状腺功能检测的阳性率较低。明显的甲状腺功能减退和亢进与便秘或腹泻均无显著关联。对于没有严重甲状腺疾病全身表现的患者,常规甲状腺检测对肠道症状的临床实用性可能较低。